Can Alignment Healthcare cover its short-term obligations?

Its current ratio is 1.58 — current assets exceed current liabilities.

Where does Alignment Healthcare's balance sheet data come from?

Every line is extracted from Alignment Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Alignment Healthcare ALHC Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$577.94M+32.9%	$434.94M+112%	$204.95M-50.0%	$409.55M-12.2%
Short-term investments	$28.41M-24.8%	$37.79M-67.4%	$115.91M—	$0—
Restricted cash	——	——	——	——
Accounts receivable, net	$970.03M+51.3%	$641.04M+45.9%	$439.47M+20.8%	$363.66M+63.7%
Prepaid expenses and other current assets	$389.84M+98.0%	$196.91M-12.8%	$225.93M+55.0%	$145.77M+26.1%
Total current assets	$951.58M+43.8%	$661.64M+36.8%	$483.54M-11.2%	$544.55M-1.5%
Property and equipment, net	$64.25M-4.3%	$67.14M+29.4%	$51.9M+39.6%	$37.17M+22.4%
Accumulated depreciation	$179.13M+19.9%	$149.39M+20.8%	$123.69M—	——
Goodwill	$32.06M-7.9%	$34.83M0.0%	$34.83M0.0%	$34.81M-0.9%
Intangible assets, net	$4.55M0.0%	$4.55M-13.4%	$5.25M-4.1%	$5.48M—
Other non-current assets	$6.33M+3.9%	$6.09M-4.9%	$6.41M+6.1%	$6.04M+28.2%
Held-to-maturity securities	$29.46M-58.6%	$71.12M-39.4%	$117.34M—	——
Total assets	$1.07B+36.3%	$782.06M+32.1%	$591.88M-6.6%	$633.86M+0.5%
Accounts payable	$33.28M+50.4%	$22.13M-5.9%	$23.51M-27.2%	$32.29M+85.2%
Accrued expenses	$49.01M+22.7%	$39.93M+17.1%	$34.11M—	——
Current portion of long-term debt	$0—	$0—	$0—	$0—
Operating lease liabilities, current	$1.87M+54.5%	$1.21M-24.1%	$1.6M-60.6%	$4.05M+13.8%
Finance Lease Liability, Current	$85K—	$0-100%	$120K-21.1%	$152K+3.4%
Total current liabilities	$556.87M+58.3%	$351.85M+33.8%	$263.02M+14.4%	$229.96M+37.5%
Long-term debt	$323.18M+0.5%	$321.43M+98.6%	$161.81M+0.6%	$160.9M+6.8%
Finance Lease Liabilities (Total)	$272K—	——	$120K-55.9%	$272K-36.7%
Operating Lease Liabilities (Total)	$8.15M-9.9%	$9.05M-14.4%	$10.57M+38.6%	$7.63M-25.6%
Finance lease liabilities	$185K—	$0—	$0-100%	$120K-57.6%
Reserve for insurance claims	$297.37M+76.6%	$168.36M+76.0%	$95.66M+7.7%	$88.81M—
Total liabilities	$886.51M+30.2%	$681.11M+57.0%	$433.81M+9.9%	$394.56M+21.5%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	1B+520,733%	192K+1.6%	189K+1.1%	187K0.0%
Additional paid-in capital	$1.19B+7.2%	$1.11B+6.8%	$1.04B+6.9%	$970.18M+9.2%
Retained earnings	-$1.01B-0.1%	-$1.01B-14.5%	-$880.26M-20.2%	-$732.24M-25.7%
Total stockholders' equity	$179.28M+79.5%	$99.85M-36.4%	$156.95M-34.1%	$238.13M-22.2%
Total liabilities and stockholders' equity	$1.07B+36.3%	$782.06M+32.1%	$591.88M-6.6%	$633.86M+0.5%
Allowance for Doubtful Accounts	$833K—	$0—	$0—	——
Allowance for Doubtful Accounts Receivable (Current)	$833K—	$0—	$0—	——
Other Receivables	$22.43M+42.4%	$15.75M+89.2%	$8.33M—	——
Deferred Tax Assets and Other Non-Current Assets	$6.33M+3.9%	$6.09M-4.9%	$6.41M+6.1%	$6.04M+28.2%
Goodwill and Intangible Assets, Net	$36.61M-7.0%	$39.38M-1.8%	$40.08M-0.5%	$40.29M+14.7%
Net Operating Loss Carryforwards	$95.33M-74.5%	$374.19M—	——	——
Other intangible assets—net	$4.55M0.0%	$4.55M-13.4%	$5.25M-4.1%	$5.48M—
Goodwill and intangible assets, net	$36.61M-7.0%	$39.38M-1.8%	$40.08M-0.5%	$40.29M+14.7%
Right of use asset, net	$7.02M-10.2%	$7.82M-21.5%	$9.96M—	——
Other non-current assets	$6.33M+3.9%	$6.09M-4.9%	$6.41M+6.1%	$6.04M+28.2%
Property, plant and equipment at cost	$243.38M+12.4%	$216.53M+23.3%	$175.59M—	——
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$28.41M-24.8%	$37.79M-67.4%	$115.91M—	$0—
Software and Technology Licenses, Net	$6.33M+3.9%	$6.09M-4.9%	$6.41M+6.1%	$6.04M+28.2%
Accrued Manufacturing Costs	$49.01M+22.7%	$39.93M+17.1%	$34.11M—	——
Accounts payable and other current liabilities (Note 11)	$33.28M+50.4%	$22.13M-5.9%	$23.51M-27.2%	$32.29M+85.2%
Compensation and benefits	$49.01M+22.7%	$39.93M+17.1%	$34.11M—	——
Liability for Claims and Claims Adjustment Expense	$474.57M+63.8%	$289.79M+41.1%	$205.4M—	——
Medical expenses payable	$474.57M+63.8%	$289.79M+41.1%	$205.4M+20.7%	$170.14M+35.2%
Reserve for Incurred But Not Reported (IBNR) Claims	$297.37M+76.6%	$168.36M+76.0%	$95.66M+7.7%	$88.81M—
Debt Maturity - 2024	——	——	——	——
Debt Maturity - 2027	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$6.82M-20.4%	$8.57M+169%	$3.19M—	——
Total debt	$331.6M+0.3%	$330.48M+91.6%	$172.5M+2.2%	$168.8M+4.7%
Total Carrying Value of Debt	$330M0.0%	$330M+100%	$165M—	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.00—	——
Common Stock Shares Issued	204.2M+6.5%	191.8M+1.5%	189M—	——
Common Stock Shares Outstanding	$20M+789%	$2.25M+2,748%	$79K—	——
Convertible Preferred Stock Authorized Shares	100M0.0%	100M0.0%	100M—	——
Convertible Preferred Stock Issued Shares	0—	0—	0—	——
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$205K+6.8%	$192K+1.6%	$189K+1.1%	$187K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.00—	——
Share-Based Payment Award Options Outstanding - Number	7.4M-15.5%	8.8M-4.1%	9.1M—	——
Weighted Average Exercise Price of Exercisable Options	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	$17.05+0.5%	$16.97+0.1%	$16.95—	——
Cumulative Cost Basis	$243.38M+12.4%	$216.53M+23.3%	$175.59M—	——
Accounts Receivable, after Allowance for Credit Loss	$253.21M+64.5%	$153.9M+28.5%	$119.75M—	——
Accounts Receivable, Allowance for Credit Loss	$833K—	$0—	$0—	——
Allowance for doubtful accounts	$833K—	$0—	$0—	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$0—	——
Common stock, shares authorized (in shares)	$1B0.0%	$1B0.0%	$1B—	——
Common stock, shares issued (in shares)	$204.15M+6.5%	$191.78M+1.5%	$188.95M—	——
Common Stock, Shares, Outstanding	$204.15M+6.5%	$191.78M+1.5%	$188.95M—	——
Other Contractual Commitments	$52.41M+99.0%	$26.34M-25.9%	$35.53M—	——
Long-term debt, gross	$330M0.0%	$330M+100%	$165M—	——
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$6.82M-20.4%	$8.57M+169%	$3.19M—	——
Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration	$95.33M-74.5%	$374.19M—	——	——
Current maturities of long-term debt	$85K—	$0-100%	$120K-21.1%	$152K+3.4%
Finite-Lived Intangible Assets, Accumulated Amortization	$3.33M0.0%	$3.33M-3.8%	$3.47M—	——
Goodwill, Gross	$32.06M-7.9%	$34.83M0.0%	$34.83M—	——
Intangible Assets, Gross (Including Goodwill)	$39.94M-6.5%	$42.71M-1.9%	$43.54M—	——
Lease, Liability, Noncurrent	$6.47M-17.5%	$7.84M-12.7%	$8.97M—	——
Capitation payable, risk-sharing payable, and other	——	——	——	——
Capitation and risk-sharing payable	$85.08M+63.6%	$52.02M+2.2%	$50.89M—	——
Other	$92.12M+32.7%	$69.42M+18.0%	$58.84M—	——
Fair value of long-term debt	$514.61M—	——	——	——
2028	——	——	——	——
2029	——	——	——	——
2030	——	——	——	——
2027	——	——	——	——
Remainder of 2026	——	——	——	——
Money Market Funds At Carrying Value	$216.16M—	——	——	——
Other receivables	$22.43M+42.4%	$15.75M+89.2%	$8.33M—	——
Pharmacy rebate receivables	$179.2M+60.3%	$111.81M+47.3%	$75.89M—	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$0—	——
Preferred Stock, Shares Authorized	$100M0.0%	$100M0.0%	$100M—	——
Preferred Stock, Shares Issued	$0—	$0—	$0—	——
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	——
Restricted marketable debt and other securities (Note 6)	$2.35M+1.0%	$2.32M+32.3%	$1.76M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$7.41M-15.5%	$8.76M-4.1%	$9.14M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$17.05+0.5%	$16.97+0.1%	$16.95—	——
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$20M+789%	$2.25M+2,748%	$79K—	——
Remainder of Fiscal Year 2024	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Alignment Healthcare cover its short-term obligations?: Its current ratio is 1.58 — current assets exceed current liabilities.
Where does Alignment Healthcare's balance sheet data come from?: Every line is extracted from Alignment Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.